Is my tumor MSI-High or MSS, and how does this affect treatment
What these terms mean:
MSI-High (MSI-H) means your tumor has many DNA replication errors that weren't corrected—like a typewriter without spell-check. Think of it as your tumor's "repair system" being broken.
MSS (Microsatellite Stable) means your tumor's DNA repair system is working normally, so fewer errors accumulated.
Why it matters for treatment:
According to NCCN Guidelines, MSI status significantly influences whether chemotherapy helps:
- Stage II MSI-H tumors: May have a better prognosis on their own and may NOT benefit from standard fluoropyrimidine chemotherapy alone
- Stage III MSI-H tumors: Treatment decisions are more complex and depend on other factors
- MSS tumors: Generally benefit from adjuvant (post-surgery) chemotherapy
For metastatic disease, MSI-H status opens the door to checkpoint inhibitor immunotherapy (drugs like nivolumab or pembrolizumab), which can be highly effective because these tumors trigger stronger immune responses.
What you need to do:
Check your pathology report for "MSI" or "mismatch repair (MMR)" testing results. If you don't see it listed, ask your oncologist whether this test was performed—NCCN Guidelines recommend universal MSI testing for all newly diagnosed colon cancer patients.
Once you have that result, your doctor can explain exactly how it shapes YOUR specific treatment plan.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Colon Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated July 14, 2026. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Colon Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Colorectal Cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Colorectal Cancer
- How does ALK rearrangement affect Colorectal Cancer treatment
- Colorectal Cancer and another chronic condition — how does this affect treatment
- How does mismatch repair deficiency affect Colorectal Cancer treatment
- How does NTRK fusion affect Colorectal Cancer treatment options
- What factors affect prognosis for Colorectal Cancer
- What does tumor mutational burden (TMB) mean for Colorectal Cancer
- A poorly differentiated tumor, what chemo is recommended
- If my tumor is found to have a BRAF mutation, what specific treatment options would my oncologist recommend, and how...